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DOI 10.1016/j.ccr.2011.03.011SUMMARYTissue microenvironment is an important determinant of carcinogenesis. We demonstrate that ionizing radi-
ation, a known carcinogen, affects cancer frequency and characteristics by acting on the microenvironment.
Using a mammary chimera model in which an irradiated host is transplanted with oncogenic Trp53 null
epithelium, we show accelerated development of aggressive tumors whose molecular signatures were
distinct from tumors arising in nonirradiated hosts. Molecular and genetic approaches show that TGFbmedi-
ated tumor acceleration. Tumor molecular signatures implicated TGFb, and genetically reducing TGFb abro-
gated the effect on latency. Surprisingly, tumors from irradiated hosts were predominantly estrogen receptor
negative. This effect was TGFb independent and linked to mammary stem cell activity. Thus, the irradiated
microenvironment affects latency and clinically relevant features of cancer through distinct and unexpected
mechanisms.INTRODUCTION
Currently, very little is known about how early changes in the
microenvironment contribute to breast cancer. Ionizing radiation
is one of a few demonstrable human breast carcinogens (Land
et al., 1980). The prevailing view is that radiation induces cancer
through DNA damage (National Research Council (U.S.).
Committee to Assess Health Risks from Exposure to Low LevelSignificance
Compared to sporadic breast cancer, women treated with rad
onset breast cancer that is more likely to be estrogen receptor n
model shows that host irradiation alone can reduce latency,
receptor-negative cancers. Thus, changes to the stromal mic
of the features that are observed in radiation-preceded breas
to identify distinct mechanisms acting via TGFb activity and
biology significantly alters cancer molecular signatures and tha
ical conduit for cancer risk in humans.
640 Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc.of Ionizing Radiation, 2006). However, this viewpoint is an over-
simplification that is inconsistent withmany experimental studies
showing that ionizing radiation evokes acute and persistent,
short and long-range effects (Kaplan et al., 1956; Ehrhart et al.,
1997; Amundson et al., 1999b; Mancuso et al., 2008). We and
others have postulated that radiation’s carcinogenic potential
is perpetuated via so-called nontargeted radiation effects that
alter signaling and change the microenvironment (Barcellos-iation for childhood cancers are often diagnosed with early-
egative and have aworse prognosis. Ourmammary chimera
promote aggressive tumor growth, and increase estrogen
roenvironment rather than DNA damage account for many
t cancer. We combined molecular and genetic approaches
stem cell deregulation. Our study further shows that host
t suchmicroenvironmental changes are an important biolog-
Cancer Cell
Host Irradiation Promotes Breast CancerHoff et al., 2005; Durante and Cucinotta, 2008;Wright, 2010). We
established a radiation-chimera model in which the mammary
gland is cleared of endogenous epithelium before the mouse is
irradiated and subsequently transplanted with unirradiated,
nonmalignant epithelial cells (Barcellos-Hoff and Ravani, 2000).
Mice irradiated with a high dose (400 cGy) and transplanted up
to 2 weeks later with unirradiated, immortalized mammary
epithelial cells develop aggressive tumors even though normal
outgrowths form in nonirradiated hosts.
The challenge remains to demonstrate that nontargeted radi-
ation effects contribute to carcinogenesis following doses
relevant to human populations. In the present studies we use
the radiation chimera to assess the frequency, rate, and charac-
teristics of carcinogenesis in a donor epithelium primed to
undergo neoplastic transformation by genetic loss of p53.
Carcinogenesis in Tp53 null tissue is similar to human breast
cancer in that tumors exhibit genomic instability, differential
expression of estrogen receptor (ER) a, and heterogeneous
histology (Jerry et al., 2000; Medina et al., 2002). Over the course
of 1 year, most (70%) Trp53 null mammary epithelial trans-
plants in wild-type mouse mammary stroma progress from
normal ductal outgrowths to ductal carcinoma in situ to invasive
breast carcinomas (Medina et al., 2002). To test whether radia-
tion nontargeted effects on the microenvironment contribute to
its carcinogenic action, only the host was exposed to radiation
doses (10–400 cGy) prior to transplanting Trp53 null mammary
gland fragments.
RESULTS
Host Irradiation Affects Development of Spontaneous
Trp53 Null Breast Cancer
The radiation-chimera model consists of surgically clearing the
mammary epithelium from the inguinal glands of 3-week-old
BALB/c mice, irradiating or sham irradiating these mice at 10–
12 weeks of age, and transplanting 3 days later with syngeneic
mammary fragments (Figure 1A). Based on our prior study using
400 cGy, we first asked whether host irradiation was sufficient to
promote cancer of orthotopically transplanted wild-type
mammary epithelium. Mice were monitored by palpation for
60 weeks, yet no palpable tumors arose from wild-type epithe-
lium in either sham or irradiated hosts. These data indicated
that neither transplantation itself (Figure 1B) nor host irradiation
alone is sufficient to induce neoplastic transformation in wild-
type epithelium.
In contrast to wild-type epithelium,most Trp53 null transplants
developed palpable tumors. The percentage of successful trans-
plants into cleared fat pads was 81% ± 2% SD in control hosts
(n = 55) and 77% ± 10% in irradiated hosts (n = 54) in four
consecutive experiments. Syngeneic Trp53 null mammary
outgrowths in wild-type hosts are morphologically normal at
weeks 6 and 10 post transplantation (Figures 1C and 1D).
Tumors developed with a similar mean latency in sham (61 ±
7.4 SD weeks) and irradiated (63 ± 5.5 SD) hosts (Figure 1E),
which were confirmed to contain the p53 null allele (Figure 1F).
The growth rate of tumors that arose in hosts irradiated with
400 cGy was increased in comparison to sham-irradiated hosts
(Figure 1F). As described previously, Trp53 null mammary
tumors were diverse in terms of histology, proliferation, lineagemarkers, and ER (Figure 1H). Tumor histological types included
poorly differentiated, solid adenocarcinomas with little stroma,
spindle-cell morphology, and squamous cell carcinomas.
Unexpectedly, the frequency of Trp53 null tumors in irradiated
hosts was reduced by 21% (p < 0.01) compared to sham-irradi-
ated hosts. Because women who receive an ovarian dose
of >500 cGy have a greatly reduced risk for breast cancer (Inskip
et al., 2009) and ovariectomy decreases cancer development by
Trp53 null mammary transplants (Medina et al., 2003), we
considered the possibility that radiation exposure compromised
ovarian function. To test this idea, Trp53 8-week ductal
outgrowths were examined. Outgrowths from 400 cGy irradiated
mice were noted to have thinner mammary gland ducts and
significantly (p < 0.001) fewer branches (0.31 ± 0.1/unit length)
compared to controls (0.56 ± 0.1). This defect in branching
morphogenesis persisted 1 year after transplantation into hosts
irradiated with 200 cGy or more, but Trp53 null mammary
outgrowths in hosts irradiated with 100 cGy or less were histo-
logically indistinguishable from those of sham-irradiated mice
(Figures 1H–1K).
To avoid confounding by ovarian effects, and to better repre-
sent relevant human exposures, we focused subsequent radia-
tion-chimera experiments on doses of 10–100 cGy (Figure 2).
The rate at which tumors developed in transplants increased in
irradiated hosts compared to sham-irradiated hosts (Figure 2A).
When all radiation dose groups were pooled and compared to
the sham-irradiated control group, host irradiation unequivocally
accelerated tumorigenesis (Figure 2B). The first tumors were
detected at about 170 days post transplantation in both irradi-
ated and nonirradiated hosts, but by 300 days, 100% of trans-
plants in hosts irradiated with either 10 or 100 cGy had
developed tumors compared to 54% of transplants in unirradi-
ated hosts. Median tumor latency was significantly reduced by
72 days for 10 cGy, 82 days for 100 cGy, and 63 days for all
doses pooled compared to sham-irradiated mice. At 365 days
after transplantation, all outgrowths in irradiated hosts (n = 45)
had developed tumors compared to 69% (n = 20/29) in sham-
irradiated mice (Figure 2C; p < 0.05, chi-square test). Further-
more, as was observed in hosts irradiated with 400 cGy, tumor
growth rate increased with increasing host radiation exposure
(Figure 2D). Thus, low doses of ionizing radiation altered the
course of carcinogenesis, evenwhen radiation was administered
in the absence of the epithelium and exposure preceded detect-
able cancer by many months.
Molecular Features of Breast Cancer Are Altered
by Host Irradiation
Breast cancer in women is a heterogeneous disease in terms of
histology, marker expression, and prognosis (Parise et al., 2009),
as are breast tumors that develop in Trp53 knockout mice (Jerry
et al., 2000). We next considered the possibility that acceleration
in irradiated hosts was because the specific tumor type was
affected. We classified Trp53 null tumors arising in unirradiated
hosts and low-dose irradiated hosts by histological type
(n = 81). Most tumors from unirradiated mice were adenocarci-
nomas (43%) or spindle cell carcinomas (33%); the remaining
tumors were myoepitheliomas or squamous carcinoma (see
Table S1 available online). Tumor typewas not significantly asso-
ciated with host irradiation status or latency per se.Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc. 641
Figure 1. Host Irradiation Affects Tumor Features
(A–E) (A) Schematic of the experimental protocol. Whole mounts of (B) cleared mammary gland, (C) 6-week Trp53 null outgrowth, (D) 10-week Trp53 null
outgrowth, and (E) tumor-bearing Trp53 null outgrowth. Asterisk (*) marks mammary lymph nodes.
(F) Examples of tumor genotype defined by PCR of wild-type and null allele.
(G) Tumor growth rate as a function of host irradiation. Tumors that arose in irradiated hosts grew significantly faster compared to those in the sham group
(top panel). Tumor doubling time was approximately 2 days in the irradiated host group compared to 8 days in the sham group (bottom panel).
(H) Histopathology of Trp53 mouse mammary tumors: left, adenocarcinoma; middle, squamous cell carcinoma; and right, spindle cell carcinoma. Scale bar,
100 mm.
(I–L) Whole mounts from Trp53 null epithelium transplanted to mice that were sham irradiated (I) or irradiated with (J) 100 cGy, (K) 200 cGy, or (L) 400 cGy before
transplantation. Doses of 200 cGy and above exhibit reduced branching, thinner ducts (arrows), and lack of alveolar buds (arrowheads), indicative of ovarian
insufficiency. Scale bar, 1 mm.
Cancer Cell
Host Irradiation Promotes Breast CancerTo further explore how tumors arising in irradiated hosts are
distinct from those that occur in nonirradiated hosts, we used
Affymetrix gene chips to profile total RNA from individual adeno-
carcinoma or spindle cell tumors that arose in nonirradiatedmice
(n = 9) and irradiated mice (n = 23). Raw data were background
normalized, and unsupervised hierarchical clustering (UHC) was
performed using a 1 SD filter cutoff of gene expression change of
at least 2-fold that yielded 2547 probes. UHC did not readily
separate tumors on the basis of host irradiation status (Fig-
ure 3A). To explicitly compare tumors from irradiated hosts and
nonirradiated hosts (reference group), we performed a super-
vised analysis of genes with a p value of 0.05 and a minimum
2-fold change, using significance of analysis of microarray
(SAM) methodology and permutation analysis under a leave-
one-out bootstrap scheme (Tusher et al., 2001). This strategy re-
sulted in 24 genes, which we referred to as the irradiated host
core signature (24-IHC), enriched in tumors that developed in642 Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc.irradiated hosts. Using the 24-IHC gene expression list, UHC
segregated tumors of nonirradiated hosts from those of irradi-
ated hosts (Figure 3B). Ingenuity pathway analysis (IPA) resulted
in two major networks (Figures S1A and S1B). The first contain-
ing 12/21 identified genes described a network characterizing
cell morphology and amino acid metabolism; the second con-
taining 10/21 identified genes was associated with cellular
movement, cellular growth and proliferation, and cancer. Quan-
tiGene validation of expression differences confirmed 22 genes
of the 24-IHC; this subset still segregated tumors from irradiated
or nonirradiated hosts.
To define the global biology of tumors arising in irradiated
hosts, a gene list was generated using a 1.5-fold change
threshold (Table S2), which also segregated tumors from irradi-
ated or nonirradiated hosts (Figure S1C). IPA using these 156
genes invoked cell-cell interaction, cancer, hematological
system development, and DNA replication, recombination, and
Figure 2. Low-Dose Irradiation Promotes Tumor Development
(A) Analyses of the time-to-tumor occurrence of tumors in sham (black) and
hosts irradiatedwith 10 cGy (blue), 50 cGy (gray), or 100 cGy (red). Significance
was calculated by the log rank test.
(B) Tumor occurrence in transplants pooled from all radiation dose groups
(purple, n = 45) compared to sham-irradiated controls (black, n = 29) was
accelerated (p < 0.0005, log rank test).
(C) Tumor frequency at experiment termination in each dose group (sham,
20/29; 10 cGy, 14/14; 50 cGy, 17/17; 100 cGy, 14/14) was significantly
increased (*p < 0.05, chi-square test) compared to sham-irradiated mice.
(D) Trp53 null tumor growth rate was increased in hosts previously irradiated
with 100 cGy (open symbols) compared to sham (closed symbols) hosts
(mean + SEM). Host irradiation at lower doses showed a similar trend but with
wider variance.
See also Table S1.
Cancer Cell
Host Irradiation Promotes Breast Cancerrepair (Figures 3C and 3D). IPA analysis of the 156-IHC also
revealed enrichment for genes involved in leukocyte chemoat-
traction and binding (Figure 3E; p = 0.007), monocyte maturation
(Figure 3F; p = 0.006), and proliferation of tumor cell lines (Fig-
ure 3G; p = 0.0007).
The top-ranked networks contained a node occupied by the
cytokine TGFb1, which although not transcriptionally regulated,
is known to play a central role in the response of tissues to
radiation. Consistent with this, we found that the 156 gene
list significantly overlapped (p % 0.01) gene lists describing
mouse mammary tumors driven by cooperation between Wnt
and TGFb (Labbe et al., 2007). Previous work from our group
has shown that TGFb is persistently activated in the irradiated
mouse mammary gland (Barcellos-Hoff et al., 1994; Ehrhart
et al., 1997). Thus, we hypothesized the TGFb mediates tumor
promotion of Trp53 null transplants in irradiated wild-type
mice.
TGFb Mediates Persistent Tissue Radiation Responses
To determine the extent to which radiation changes in gene
expression can be attributed to TGFb, we next conducted
comprehensive analysis of the contribution of TGFb signaling
in irradiated mammary gland by expression profiling Tgfb1
heterozygote and wild-type mammary glands at 1 and 4 weeks
after whole-body exposure to 10 cGy, the lowest dose used in
the tumor experiment. Microarray analysis showed that radiation
regulated 178 identified genes (p = 0.05; 1.25-fold differences)
similarly in Tgfb1 wild-type and heterozygote mammary gland
(Figure 4A; Table S3), which constitutes those genes that areindependent of TGFb dose. The top downregulated genes in
both irradiated genotypes suggested that epithelial cell differen-
tiation was affected. Downregulation of amphiregulin (Areg),
inhibin beta b (Inhibb), Wnt5a, and suppressor of cytokine-
signaling 3 (Socs3) also suggest decreased differentiation.
Upregulated genes included Adamts18, which is a disintegrin-
like and metallopeptidase with thrombospondin type 1 motif
indicative of extracellular matrix remodeling, heat shock protein
8 (Hspa8) reflecting persistent stress, and chemokine (C-X-C
motif) receptor 4 (Cxcr4) associated with expanding vascular
networks. Consistent with these, IPA networks invoked antigen
presentation, cell-to-cell signaling and interaction, hematolog-
ical system development, and function.
In contrast, more than twice as many genes (n = 488) were
regulated by radiation in a TGFb dose-dependent manner (Fig-
ure 4B). TGFb transcriptional targets, including Tgfbi, Col1a1,
and Gadd45b, were increased in the wild-type but not Tgfb1
heterozygote gland, consistent with prior studies showing that
radiation induces TGFb activation (Barcellos-Hoff, 1993). IPA
of genes regulated only in wild-type mice (Table S4) and
TGFb-dependent, radiation-regulated genes (Table S5) identi-
fied cell-to-cell signaling, cell signaling and development, and
cancer as the top wild-type networks. These analyses support
the premise that a low radiation dose elicits persistent changes
in gene expression (Amundson et al., 1999a), one-third of which
are independent and two-thirds of which are dependent upon
TGFb gene dose. In contrast, antigen presentation, cellular
assembly and organization, and cell cycle were identified in the
expression profiles of irradiated Tgfb1+/ mammary glands
compared to unirradiated tissue, which implicates TGFb
signaling as a critical determinant of the pattern of radiation
response. We noted that 29 genes regulated by radiation in
mammary gland overlapped the 156-IHC list from tumors arising
in irradiated hosts.
TGFb Mediates Tumor Latency in Irradiated Hosts
Although the specific epithelial actions of TGFb suggest that it
functions as a tumor suppressor early in cancer (Cui et al.,
1996), to our knowledge, its role in cancer development in the
context of irradiated tissue is unknown. To investigate whether
host TGFb contributes to the radiation effect on Trp53 null carci-
nogenesis, the radiation-chimera experiment was repeated
using syngeneic Tgfb1+/ hosts. Strikingly, Tgfb1+/ host irradi-
ation did not affect the frequency, latency, or growth rate of
Trp53 null carcinomas (Figures 5A–5D), or molecular character-
istics (Table S6), providing strong genetic proof that a critical
threshold of TGFb is an essential facet of radiation-induced
tumorigenesis and acceleration.
Given that genetically reducing host TGFb rescued tumor
promotion caused by host irradiation, we asked whether the
24-IHC derived from tumors of irradiated wild-type hosts could
segregate tumors that arose in nonirradiated Tgfb1+/ mice
(n = 6) from those that arose in irradiated hosts (n = 10). Neither
the 24-IHC nor a similar SAMbootstrap analysis could segregate
tumors from nonirradiated versus irradiated Tgfb1+/ hosts (Fig-
ure 3H). Because radiation did not accelerate carcinogenesis in
the Tgfb1+/ hosts, these tumors can be considered a validation
set of the distinct biology of the microenvironment that acceler-
ates carcinogenesis.Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc. 643
Figure 3. Tumors from Irradiated Hosts
Exhibit Distinct Gene Expression
(A) UHC of Trp53 null mouse tumors based on SD
of 1.0 from sham (red) or irradiated (purple) hosts
that were either spindle cell carcinoma (gold) or
adenocarcinoma (turquoise). Latency for each
tumor is listed below the column.
(B) Supervised hierarchical clustering of permu-
tation analysis using SAM with a threshold of 2-
fold change identified 24 genes that classified
tumors that arose in irradiated (purple) hosts
versus sham irradiated (red). The genes of the
irradiated host core (24-IHC) are listed at the right.
IPA networks of gene interactions among the 24-
IHC include cell-to-cell signaling and interaction,
cellular development, hematopoiesis, and cellular
assembly and organization.
(C and D) IPA network of the top two gene
networks generated from the 156-IHC. Note that
TGFb is a central node in both networks (yellow
circle). IPA of 156-IHC also revealed enrichment
for genes involved in (E) leukocyte chemo-
attraction and binding (p = 0.007), (F) monocyte
maturation (p = 0.006), and (G) proliferation of
tumor cell lines (p = 0.0007). Red ovals, induced;
green ovals, suppressed. (H) Dendrogram of
tumor expression profiles based on the 24-IHC
genes indicates that UHC did not segregate
tumors from sham-irradiated (red) versus irradi-
ated (purple) Tgfb1+/ mice. See also Figure S1
and Table S2.
Cancer Cell
Host Irradiation Promotes Breast CancerGiven that reducing host TGFb abolished the radiation effect
on tumor latency, we next sought to test whether chronic
TGFb could alter malignant progression. To do so we used
a derivative of COMMA-1D cells, CDbGeo, which produce ductal
and alveolar structures when transplanted in cleared fat pads
(Deugnier et al., 2006) and exposed them to 14 days of contin-
uous TGFb treatment (5 ng/ml) in vitro. These and the parental
cells were then injected (500,000 cells/gland) into contralateral
inguinal cleared mammary fat pads of WT BALB/c host mice
(n = 15). As shown previously (Barcellos-Hoff and Ravani,
2000), untreated parental cells injected into cleared mammary
glands mostly gave rise to ductal outgrowths (Figure 5E) and
a few nodular tumors (two of 15; Figure 5F). In contrast,
TGFb-treated CDbGeo cells rapidly formed solid tumors (Fig-
ure 5G) with a mean latency of 44 days, such that by 9 weeks
all fat pads had tumors compared to 13% of those injected
with parental cells (Figure 5H). Together, these data support644 Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc.chronic TGFb activity as the mechanism
by which host irradiation accelerates
Trp53 null mammary carcinogenesis.
Host IrradiationMediates Tumor ER
Status Independently of TGFbGene
Dosage
The presence of ER is perhaps the most
important clinical marker in breast cancer
and is associated with distinct risk
factors, pathological features, and clin-
ical behavior (Jensen and Jordan, 2003).We determined the ER status of Trp53 null tumors using the
Allred scoring system (Harvey et al., 1999). Host irradiation
significantly increased development of ER-negative tumors
(p = 0.002, Fisher’s exact test). Of tumors that arose in sham-irra-
diated hosts, 65% were ER positive (28/45, both genotypes)
compared to only 35%of tumors (33/93, pooled radiation doses,
both genotypes) in irradiated hosts (Figure 6A). This effect of host
irradiation to increase ER-negative tumors was observed in both
genotypes irradiated with 10 cGy (p < 0.05; Figure 6B) and,
therefore, was not associated with the effect of radiation on
latency per se.
To confirm the distinct biology associated with ER status, we
localized progesterone receptor (PR) in a subset of 20 tumors.
Most (eight of ten) ER-positive tumors were PR positive, whereas
few (four of ten) ER-negative tumors were PR positive. We
considered the possibility that the frequency of ER-positive cell
Trp53 null outgrowths was affected by host irradiation
Figure 4. A Single Low Radiation Dose
Elicits Persistent Changes in Gene Expres-
sion that Are Highly Modulated by TGFb
(A) Heat map based on PTM (p < 0.05; threshold of
1.25-fold) for radiation-induced genes common to
mammary gland from Tgfb1 wild-type (black) and
heterozygote (gray) littermates at 1 week (orange)
and/or 4 weeks (blue) after sham irradiation
(yellow) or 10 cGy (green) exposure.
(B) Heat map based on PTM (p < 0.05) and
threshold of 1.25-fold change for genes that are
downregulated (blue) or upregulated (red) in
mammary gland from irradiated wild-type (black)
but not Tgfb1 heterozygote (gray) littermates at
1 week (orange) or 4 weeks (blue) after sham
(yellow) or 10 cGy (green) radiation exposure.
(C) IPA networks of the genes upregulated by
radiation in both genotypes invoked cellular
growth and proliferation, reproductive system
development and function, and organismal
development. Note TGFb is a node (yellow circle).
(D) IPA network of the genes induced by radiation
only in wild-type hosts included functions involved
in hematological disease, metabolic disease, and
connective tissue development and function.
See also Tables S3–S5.
Cancer Cell
Host Irradiation Promotes Breast Cancer(Figure 6C), but the frequency of ER-positive cells was unaf-
fected in irradiated compared to control hosts (Figure 6D).
What determines the prevalence of ER-negative cancer is not
well understood (Allred et al., 2008). ER-negative breast cancer
is most frequent in young women and certain racial groups,
particularly African-American women (Parise et al., 2009). The
observation that irradiated hosts were significantly more likely
to give rise to ER-negative and PR-negative tumors implicates
radiation-induced heterotypic signaling in determining critical
clinical features of breast cancer. We then asked how different
the expression profiles of ER-negative tumors were in sham
and irradiated hosts as a means to infer whether they develop
via similar paths. SAM-tandem-bootstrap identified 115 genes
(Table S7) that cluster ER-negative tumors from irradiated versus
sham-irradiated hosts (Figure 6E), but not ER-positive tumors
(Figure 6F).
It is has been proposed that breast cancer heterogeneity is
determined in part by the cell of origin and its position within
the epithelial lineage hierarchy of normal organs (Sell and Pierce,
1994). A corollary is tumors retain fundamental programming
that remains evident in the biology, behavior, and signature of
the cancer subtype. Indeed, the expression profiles of isolated
mammary stem cells (MaSCs), which are thought to give riseCancer Cell 19, 640–6to luminal progenitor (LP) cells that in
turn generate mature luminal (ML) cells,
segregate breast cancers with specific
markers and prognoses (Lim et al.,
2010). Mouse Trp53 null tumors are
similar to claudin-low breast cancer
(Prat et al., 2010), and both are enriched
in the MaSC signature (Lim et al., 2010).
Moreover, neoplastic transformation in
this model is thought to be enhanced byincreased stem cell self-renewal (Cicalese et al., 2009), which
is mediated by Notch signaling (Tao et al., 2011). Notch is pref-
erentially activated in the normal ductal luminal epithelium and
promotes commitment of MaSC in vivo (Bouras et al., 2008).
We noted significant core enrichment for the Notch pathway in
irradiated tissues of both genotypes at 4 weeks when compared
to corresponding sham controls. Activation of this pathway was
confirmed in an independent experiment using qRT-PCR of Jag1
and Rbpj, which are a key effector and transducer of Notch
signaling, respectively. Both genes are significantly induced in
Tgfb1 wild-type and heterozygote tissues following irradiation
with 10 cGy. We then used high-content image analysis to
localize epithelial Notch based on b-catenin immunoreactivity
(Figures 7C and 7D). We found that nuclear colocalization of
both proteins was significantly increased by radiation (Figures
7E and 7F). These data suggested that radiation could affect
stem cell activity by inducing key regulators of mammary self-
renewal and lineage commitment.
Because the MaSC is ER negative, as are tumors that are en-
riched in the MaSC signature, we asked whether the MaSC
profile relates to 156-IHC and ER-115 profiles (Figure 8A). Genes
upregulated in the 156-IHC showed a highly significant (p = 5.43
105) enrichment using ConceptGen for genes upregulated in51, May 17, 2011 ª2011 Elsevier Inc. 645
Figure 5. TGFb Promotes Carcinogenesis in Irradiated Hosts
(A) Kaplan-Meier analyses of the time-to-tumor occurrence in Tgfb1 hetero-
zygote hosts irradiatedwith sham (black), 10 cGy (blue), 50 cGy (gray), and 100
cGy (red). Host irradiation did not decrease tumor latency. Significance was
calculated by the log rank test.
(B) Tumor occurrence in transplants into Tgfb1 heterozygote hosts pooled
from all radiation dose groups (purple, n = 86) compared to sham-irradiated
controls (black, n = 26).
(C) Tumor incidence of Trp53 null outgrowths does not significantly increase in
irradiated Tgfb1 heterozygote hosts compared to sham hosts at 365 days post
transplantation. Sham, n = 15/26; 10 cGy, n = 21/31; 50 cGy, n = 16/22; and
100 cGy, n = 20/33. ns, not significant.
(D) Tumor growth rate was not affected by host irradiation (mean + SEM).
(E) TGFb treatment significantly (p < 0.0001) increased mammary tumor
incidence (purple) compared to control parental CDbGeo cells (red) trans-
planted to cleared mammary glands.
(F) Most CDbGeo cells give rise to ductal outgrowths, as shown in a repre-
sentative tissue section (H&E, scale bar, 50 mm).
(G) A few CDbGeo injections give rise to nodular tumors (H&E, scale bar,
50 mm).
(H) CDbGeo cells exposed to prolonged TGFb in vitro rapidly generate solid
tumors (H&E, scale bar, 50 mm).
See also Table S6.
Figure 6. The Frequency of ER-Negative Trp53 Null Tumors Is
Increased by Host Irradiation
(A) The frequency of ER-negative tumors was significantly greater (p < 0.002) in
irradiated hosts compared to sham hosts.
(B) The frequency of ER-negative Trp53 null tumors arising in hosts irradiated
with 10 cGy was significantly increased in both host genotypes (black,
p < 0.05; gray, Tgfb1+/, p < 0.05).
(C) ER immunohistochemistry in 5-week-old outgrowths of Trp53 null
mammary outgrowths; scale bar, 100 mm.
(D) The frequency of ER-positive cells in outgrowths was not affected by host
irradiation (sham hosts, 34% ± 6% SEM, n = 3 versus irradiated hosts, 31% ±
2% SEM, n = 9). NS, not significant.
(E) The ER-115 profile clusters ER-negative tumors that arose in irradiated
(purple) from sham-irradiated (red) hosts.
(F) Dendrogram showing that the ER-115 does not cluster ER-positive tumors.
See also Table S7.
Cancer Cell
Host Irradiation Promotes Breast Cancerthe MaSC profile, as was the ER-115 signature (p = 0.01). These
data suggest that tumors arising in the irradiated host have
a strong MaSC profile. Similarly, MaSC genes were significantly
enriched after irradiation in mammary gland (Figure 8B).
Together, these data suggested the hypothesis that low-dose
host irradiation might affect the mammary lineage hierarchy by
altering self-renewal in MaSCs.
To test this ideamice were irradiated with graded low doses at
3 weeks of age and cells isolated from fully mature glands were646 Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc.analyzed by FACS using Cd24med/Cd49hi mammary repopula-
tion markers (Shackleton et al., 2006). Similar cell numbers
were recovered from irradiated mouse mammary gland, which
is expected for these very low doses and the extended recovery
period. The proportion of lin- /Cd24med/Cd49hi cells in irradiated
mice was significantly increased (p < 0.05) compared to sham-
irradiated mice (Figure 8C). Note the absence of dose depen-
dence, indicating that this effect is not mediated by cell kill per
se. Functional analysis of repopulating potential is the gold stan-
dard to assess MaSCs (Purton and Scadden, 2007). Thus, we
Figure 7. Radiation Induces Notch and b-Catenin Activity
(A) Notch ligand, Jag1, is increased at 1 week, and a transducer of Notch
signaling, Rbpj, is increased at 4 weeks after irradiation as measured by
qRT-PCR (error bars, SEM).
(B) Notch ligand, Jag1, and a transducer of Notch signaling, Rbpj, are
increased at 4 weeks in irradiated Tgfb1 heterozygote mammary tissue as
measured by qRT-PCR (error bars, SEM).
(C and D) Dual immunostaining of Notch (green) and b-catenin (red) in
mammary epithelium in which nuclei are stained with DAPI (blue; scale bar,
25 mm). Arrowheads indicate cells that have high nuclear Notch and b-catenin,
which are increased in irradiated tissues (D) compared to sham-irradiated
tissue (C).
(E and F) Multiscale in situ sorting of nuclear Notch and b-catenin immuno-
reactivity shows that radiation (F; n = 486 cells) significantly increased the
frequency of Notch-positive cells (p < 0.05, Fisher’s exact test) and dual-
stained cells (p < 0.001, Fisher’s exact test) compared to sham-irradiated
tissues (E; n = 424 cells).
Figure 8. Radiation Affects the MaSC Pool
(A) The overlap between the MaSC signature (Lim et al., 2010), 156-IHC, and
ER-115 is indicated within the Venn diagram, and the p value for enrichment
determined with ConceptGen is shown outside the regions of interest.
(B) Venn diagram showing the overlap between the MaSC signature and the
genes regulated by radiation in the Tgfb1wild-type (WT) and heterozygote (HT)
mammary gland as described for (A).
(C) Radiation significantly (p < 0.01) increased the proportion of lin- /Cd24med/
Cd49hi cells determined by FACS analysis of mammary epithelial cells isolated
from tissue of mice irradiated 6 weeks before compared to sham-irradiated
mice (mean + SEM). Dose was not associated with the degree of response.
(D) The mammary-repopulating capacity of cells from mice irradiated as in (C)
is significantly increased (p < 0.05) as determined by limiting dilution estimation
(±95% CI).
(E) Schematic of distinct mechanisms by which host irradiation affects tumor
latency and type.
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Host Irradiation Promotes Breast Cancerisolated mammary cells from 8-week-old mice that were sham
irradiated or irradiated with 10 or 100 cGy at 3 weeks.
Mammary-repopulating activity increased 1.7-fold (p < 0.05)
in irradiated mice compared to sham-irradiated mice, again
without evidence of dose dependence (Figure 8D).
Thus, low doses of ionizing radiation induce a tumor-
promoting microenvironment by two distinct mechanisms (Fig-
ure 8E). One mechanism is the induction of TGFb activity that
acts to accelerate tumorigenesis. The other mechanism, which
is not affected by host Tgfb1 haploinsufficiency, irradiationCancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc. 647
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Host Irradiation Promotes Breast Cancerinduces the Notch pathway andMaSC activity that correlate with
the increased frequency of ER-negative tumors.
DISCUSSION
Although engineered mouse models have shown that microenvi-
ronment is critical in determining whether cancer ensues from
a specific oncogenic event (Bhowmick et al., 2004; de Visser
et al., 2006;Kuperwasser et al., 2004), fewstudies haveexamined
whether carcinogens modify stroma to actively participate in
multistep carcinogenesis. Here, we use the mammary chimera
model to provide compelling evidence that a known human
carcinogen, ionizing radiation, promotes breast cancer through
effects on themicroenvironment. Several features of carcinogen-
esis in the radiation chimera parallel those documented in irradi-
ated women: early onset, a more aggressive phenotype, and
worseprognosisdefinedbymarkers.We identifiedTGFbasacrit-
ical signal based on gene expression profiles of irradiated tissue
and tumors arising in irradiated hosts, and used a genetic knock-
downmodel toconfirmthat radiation-inducedhostTGFbacceler-
ated carcinogenesis. We also used this combined molecular and
genetic approach to show that the effect of radiation on tumor ER
status was independent of TGFb host status and, thus, geneti-
cally separable from the effect on latency. Rather, radiation-
induced Notch pathway activation and deregulation of MaSC
activity was correlated with ER status of tumors, a mechanism
in which radiation altered the tissue composition, which subse-
quently affects development of specific breast cancer types.
Although it is common in risk modeling to extrapolate from
high to low radiation doses, our data suggest that low radiation
doses affect cell interactions, whereas high doses also affect
host physiology. We observed that, even though mammary
outgrowth occurred efficiently, high-dose (4 Gy) host irradiation
inhibited Trp3 null tumor development and branching morpho-
genesis, consistent with ovarian hormone deficiency. Young
women whose cancer treatment induces premature ovarian
failure (Inskip et al., 2009) and postmenopausal women who
undergo radiotherapy have reduced risk for breast cancer
because ovarian hormones regulate mammary proliferation
(Doody et al., 2000).
In contrast, low radiation doses accelerated cancer and
increased tumor growth rate, even thoughmanymonths elapsed
between host irradiation and tumor appearance, suggesting
a paradigm in which radiation promotes carcinogenesis by
altered heterotypic cell interactions. Distinct from rapid molec-
ular responses to DNA damage, signals from irradiated cells
can induce a range of events both in distant unirradiated cells
and in the progeny of irradiated cells. These phenomena are en-
compassed under a class of actions now called nontargeted
effects. Some have postulated that nontargeted effects
contribute to radiation carcinogenesis (Barcellos-Hoff et al.,
2005; Wright, 2010), but the few studies that explicitly test this
hypothesis have used high doses that may alter host physiology
(Barcellos-Hoff and Ravani, 2000; Kaplan et al., 1956). The study
reported herein is near the lowest dose range at which humans
show increased cancer risk.
Prior studies using expression profiles have argued that the
biology following low-dose radiation differs from that following
high doses, but it has proven difficult to use these differences648 Cancer Cell 19, 640–651, May 17, 2011 ª2011 Elsevier Inc.to identify key drivers of processes that affect cancer risk. We
identified a gene signature that clustered tumors arising in irradi-
ated hosts from those that arose in naive hosts. Network analysis
of the 156-IHC revealed TGFb hubs and enrichment of the
TGFb-mediated genes. Our earlier functional studies showed
that radiation-induced TGFb activation in vivomediates extracel-
lular matrix remodeling, cell fate decisions, ATMkinase control of
the DNA damage response, and EMT (reviewed in Andarawewa
et al., 2007). Expression analysis of irradiated Tgfb1 heterozy-
gote and wild-type mammary gland further underscored the
considerable influence of TGFb in the tissue response to radia-
tion and motivated the radiation chimera experiment using
Tgfb1 heterozygote hosts. This model unequivocally demon-
strates that radiation-induced host TGFb mediates promotion,
even though the transplanted epithelium is competent to both
produce and respond to TGFb. Consistent with this, we found
that mammary epithelial cells chronically exposed to TGFb
in vitro readily progress to tumors in vivo.
The radiation chimera not only accelerated carcinogenesis but
altered the expression profiles of tumors that arose from unirra-
diated epithelium many months after host exposure. Broeks
et al. (2010) reported that gene expression profiles of breast
cancers from women treated with radiation for Hodgkin’s
lymphoma cluster separately compared to those occurring in
tumors from unirradiated women diagnosed at the same age
and were consistent with a more aggressive tumor type. More
to the point, young women treated with radiation for childhood
cancer not only have a significantly increased risk for breast
cancer at an early age but a much greater likelihood to have
ER-negative cancer compared to age-matched controls (Casti-
glioni et al., 2007). Importantly, even though the epithelium is
not irradiated in the radiation-chimera model, it recapitulates
all of the clinically relevant features of radiation-preceded breast
cancer. These data not only provide insights into the origin of
breast cancer but also unequivocally show that the stroma is
a pathologically relevant target of radiation.
We found that the frequency of ER-negative mammary tumors
increased in irradiated hosts, which was independent of host
Tgfb1 haploinsufficiency, and was associated with radiation-
induced Notch pathway activation and stem cell activity.
ER-negative cancers are thought to arise from the early, undiffer-
entiated cells of the mammary gland, either MaSCs or LP cells
(Visvader, 2011). We hypothesized that radiation exerts signifi-
cant effects on mammary epithelial hierarchy because the
expression profiles of tumors arising in irradiated hosts as well
as the irradiated mammary gland significantly overlapped the
MaSC profile recently described by Visvader and colleagues
(Lim et al., 2010). Lifetime breast cancer risk correlates with
factors that drive stem cell proliferation (Savarese et al., 2007).
We explicitly tested this idea using cell surface markers and
functional repopulating capacity in cells isolated from irradiated
mice. Low doses of radiation significantly increased the
mammary-repopulating activity, and could thereby increase
the number of target cells that could initiate cancer. Taken
together, the data in the radiation chimera and in women treated
with radiation for childhood cancers (Castiglioni et al., 2007) lead
to the hypothesis that aberrant heterotypic interactions induced
by radiation early in life may set the stage for stem cell expansion
and increase the risk of developing ER-negative breast cancer.
Cancer Cell
Host Irradiation Promotes Breast CancerIt has become increasingly evident that cell function and
dysfunction during cancer development are highly intertwined
with the microenvironment (Barcellos-Hoff and Medina, 2005;
Bissell et al., 2002; Gonda et al., 2009). Our studies suggest
that radiation has very early and persistent effects on the tissue
microenvironment that are critical to its carcinogenic potential.
Although radiation therapy for cancer is effective, it comes at
the price of increased cancer risk that is a life-long burden for
patients with cancer, particularly those diagnosed during child-
hood. Radiotherapy for childhood cancers in which breast is
exposed dramatically increases breast cancer at an early age
(Castiglioni et al., 2007). Our study raises the possibility that
cancer risk could be decreased by targeting host biology after
radiation.EXPERIMENTAL PROCEDURES
Mice
All animal experiments were performed at Lawrence Berkeley National Labo-
ratory with institutional review and approval. BALB/c mice were purchased
from Simonsen Laboratories (Gilroy, CA, USA) and housed four per cage,
fed with Lab Diet 5008 chow and water ad libitum. Trp53 null and Tgfb1
heterozygote BALB/c mice were bred in house under similar conditions. For
transplantation experiments the epithelial rudiments in inguinal glands of
3-week-old mice were surgically removed. These host mice were irradiated
whole body at 10–12 weeks of age to the indicated dose at a rate of 23 cGy/
min using 60Co g-radiation. Three days after irradiation, the cleared mammary
glands of host mice were transplanted with a 1 mm3 fragment of nonirradiated
Trp53 null BALB/c mammary gland harvested and pooled from three or more
inguinal glands of 8- to 10-week-old donor mice. Mice were monitored for
365 days.
An informative transplant was defined as one that had an epithelial
outgrowth evidenced by tumor development or confirmed at sacrifice at
12 months. Time to tumor occurrence was plotted using Kaplan-Meier with
significance determined by the log rank test (GraphPad Prism). Tumor growth
curves in a treatment group were fitted to an exponential curve and averaged.
Tumors were divided and frozen in liquid nitrogen, embedded in OCT, and
formalin fixed followed by paraffin embedding.
For tissue analysis, 10-week-old Tgfb1 heterozygote and wild-type mice
were injected with estrogen (1 mg) and progesterone (1 mg) dissolved in
sesame oil 2 days before irradiation with 10 cGy. The lymph node was
removed from inguinal mammary glands used to isolate RNA. For MaSC
activity, cells were isolated from five to eight mice sham or irradiated 6 weeks
before and processed for lin- /Cd24med/Cd49hi FACS analysis, as described
(Shelton et al., 2010), in three experiments with technical triplicates. Mammary
repopulation frequency was measured by limiting dilution as described (Illa-
Bochaca et al., 2010) using five cell doses and 58 mice as recipients per treat-
ment. The repopulating capacity in sham and irradiated mice was compared
using L-Calc V1.1.1 (STEMCELL Technologies).
Immunohistochemistry
Sections were deparaffinized and rehydrated prior to antigen unmasking
according to manufacturer’s instructions (Vector Labs; catalog number
H-3300), washed once with phosphate-buffered saline (PBS), and blocked
with 0.5% casein and 0.1% Tween 20/PBS for 1 hr at room temperature.
Primary antibody for ER C1355 (Millipore/Upstate; catalog number 06-935),
PR (Neomarkers), aSMA (Sigma; catalog number A2547), K6 (Covance;
catalog number PRB-169P), and K14 (Covance; catalog number PRB-155P)
was diluted in SuperBlock Blocking Buffer (Pierce; catalog number 37515)
and refrigerated overnight. The slides were washed, followed by incubation
with fluorochrome-conjugated secondary antibody, washed, and counter-
stained with DAPI (2 mg/ml; Molecular Probes). Histopathological characteris-
tics of the tumors were reviewed by two observers blinded to the experimental
details of the mouse models. Tumors were classified and staining was
analyzed by two pathologists (J.S.R.-F. and F.C.G.) as previously described(McCarthy et al., 2007). ER scoring was performed using the Allred scoring
system (Harvey et al., 1999). Notch and b-catenin dual localization was
assessed using multiscale in situ sorting (Fernandez-Gonzalez et al., 2009).Expression Profiling
Total RNA quality and quantity were determined using Agilent 2100 Bioana-
lyzer and NanoDrop ND-1000. Affymetrix mouse GeneChipMG-430 2.0 arrays
were used according to manufacturer’s protocol. Background normalization
was done using R software v2.10.1 with widgets specific to the Affymetrix
platform. UHC was done using Gene Cluster v3.0 software, and heat maps
were visualized using Java TreeView v1.1.4r3 software. No filter was used
unless specified as a SD of 1.0 relative to the expression values of that gene
across all samples. Adjusted data means of gene expression values were
centered bymedians. Gene clustering was done by an uncentered correlation,
and array clustering was done by Spearman’s rank correlation.
Affymetrix CEL files were normalized using Robust Multichip Average
algorithm (Bolstad et al., 2003) in GeneSpring GX software (Agilent Technolo-
gies), and each probe was normalized to the median value of the unirradiated
specimens for each genotype. Genes differentially regulated in mammary
gland tissues were identified by feature selection algorithm Pavlidis template
matching (Pavlidis and Noble, 2001) using a p value of <0.05 for pathway
analysis. Heat maps were incorporated in the MultiExperiment Viewer of the
TIGR TM4 Analysis package (Saeed et al., 2003). Pathways were identified
with IPA, ConceptGen (http://conceptgen.ncibi.org/core/conceptGen/index.
jsp), L2L (Newman and Weiner, 2005), or Gene Set Enrichment Analysis using
MolDig v3 database. QuantiTect primers for murine Gapdh, Notch1, Jag1,
Jag2, and Rbpj (QIAGEN) were used with QIAGEN’s QuantiTect SYBR Green
PCR Kit on a BioRad CFX96 Thermal Cycler according to manufacturer’s
protocols.Statistical Analysis
Statistical analysis was performed using Prism (GraphPad). Differences
between treatment groups was determined using the chi-square test or two-
tailed Student’s t test for differences, which were considered statistically
significant at p < 0.05.ACCESSION NUMBERS
NCBI Gene Expression Omnibus database accession number for irradiated
mammary glands and tumors is GSE18216.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and seven tables and can be found with this article online at
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